Neuraxis

NRXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$89.662 M

$7.14 -6.18%

Close of 21 Sept 2026

Revenue

$3.57M

#3337 by revenue

Earnings

-$7.80M

Loss-making

Shares outstanding

12,557,765

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#15Vivani MedicalVANI$111.9M
#16electroCoreECOR$108.1M
#17NeuraxisNRXS$89.7M
#18StreamexSTEX$83.8M
#19HyperfineHYPR$82.8M

What if Neuraxis were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,410,784

Per share 337,645× higher

Bitcoin $1.72T

$136,951.42

Per share 19,181× higher

Nvidia $5.48T

$436,372.08

Per share 61,117× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Neuraxis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.